Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bangs Laboratories is a private U.S. life science tools company that manufactures microsphere-based reagents, magnetic particles, gold nanoparticles, and analytical instrument calibrators for medical diagnostics, biopharma, clinical laboratories, and broader life science research. The company is particularly known for polymer, silica, and magnetic microspheres used in assay development, bioseparations, flow cytometry, particle sizing, and instrument standardization. Its portfolio includes custom and OEM offerings as well as branded standards and bead products for applications such as nucleic acid isolation, cell isolation, lateral flow assays, and contamination control. Founded in 1988 in Indiana, Bangs Laboratories operates as part of the Ott Scientific family alongside Polysciences and Ethos Biosciences. For a biotech analyst, this is best understood as a commercial life science tools and enabling technologies company rather than a therapeutic drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bangs Laboratories.